Concepedia

Tabletting Defects

Tabletting Defects is a pharmaceutical formulation construct that identifies deviations from the intended physical, chemical, or structural characteristics of compressed tablets arising during the tablet manufacturing process.

7

Publications

234

Citations

32

Authors

10

Institutions

Publications per year

2017–2026

4

Parents

Publications

7

Application of Melt Granulation Technology to Enhance Tabletting Properties of Poorly Compactible High-Dose Drugs

Jay Lakshman, James Kowalski, Madhav Vasanthavada et al. · Journal of Pharmaceutical Sciences · 2010 · 106 citations

, , +15

Understanding tablet defects in commercial manufacture and transfer

Akmal Hidayat Bin Sabri, Catherine Hallam, Noel A. Baker et al. · Journal of Drug Delivery Science and Technology · 2018 · 40 citations · Full text

, , +17

Improving the prediction of exceptionally poor tableting performance: An investigation into Hiestand's “special case”

Matthew P. Mullarney, Bruno C. Hancock · Journal of Pharmaceutical Sciences · 2004 · 22 citations

, , +8

Investigation of tablet disintegration pathways by the combined use of magnetic resonance imaging, texture analysis and static light scattering

Jakub Dvořák, Jan Tomáš, Denisa Lizoňová et al. · International Journal of Pharmaceutics · 2020 · 22 citations

, , +16

A bi-directional DEM-PBM coupling to evaluate chipping and abrasion of pharmaceutical tablets

Ramon Cabiscol, Jan Henrik Finke, Arno Kwade · Advanced Powder Technology · 2021 · 20 citations

, , +9

1–5 of 7

Authors

32

  1. NA
    Noel A. Baker

    University of Nottingham, United Kingdom

    1 publications · 40 citations

    1

    h-index

  2. DM
    Dean Murphy

    AstraZeneca (United Kingdom), United Kingdom

    1 publications · 40 citations

    1

    h-index

  3. AK
    Anssi-Pekka Karttunen

    University of Eastern Finland, Finland

    1 publications · 12 citations

    1

    h-index

  4. MS
    Marek Schöngut

    University of Chemistry and Technology, Prague, Czechia

    1 publications · 22 citations

    1

    h-index

  5. OK
    Ossi Korhonen

    University of Eastern Finland, Finland

    1 publications · 12 citations

    1

    h-index

1–5 of 32

Institutions

10

  1. AstraZeneca (United Kingdom)

    Cambridge, United Kingdom

    1 h-index

    4 publications

    160 citations

  2. University of Chemistry and Technology, Prague

    Prague, Czechia

    1 h-index

    4 publications

    88 citations

  3. Tris Pharma (United States)

    Monmouth Junction, United States

    1 h-index

    1 publications

    106 citations

  4. University of Nottingham

    Nottingham, United Kingdom

    1 h-index

    1 publications

    40 citations

  5. Novartis (Switzerland)

    Basel, Switzerland

    1 h-index

    1 publications

    106 citations

  6. Pfizer (United States)

    New York, United States

    1 h-index

    2 publications

    44 citations

  7. Teva Pharmaceuticals (United States)

    North Wales, United States

    1 h-index

    5 publications

    530 citations

  8. Technische Universität Braunschweig

    Braunschweig, Germany

    1 h-index

    3 publications

    60 citations

1–8 of 10

Venues

  1. Journal of Pharmaceutical Sciences

    3 publications · 140 citations

    3

    h-index

  2. European Journal of Pharmaceutical Sciences

    1 publications · 12 citations

    1

    h-index

  3. International Journal of Pharmaceutics

    1 publications · 22 citations

    1

    h-index

  4. Journal of Drug Delivery Science and Technology

    JDDST · 1 publications · 40 citations

    1

    h-index

  5. Advanced Powder Technology

    1 publications · 20 citations

    1

    h-index

1–5